nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—SHBG—metabolic syndrome X	0.536	0.627	CbGaD
Fluoxymesterone—NR3C1—metabolic syndrome X	0.318	0.373	CbGaD
Fluoxymesterone—AR—penis—metabolic syndrome X	0.00637	0.246	CbGeAlD
Fluoxymesterone—PRLR—liver—metabolic syndrome X	0.00409	0.158	CbGeAlD
Fluoxymesterone—ESR1—blood vessel—metabolic syndrome X	0.00226	0.087	CbGeAlD
Fluoxymesterone—SHBG—cardiovascular system—metabolic syndrome X	0.00143	0.0551	CbGeAlD
Fluoxymesterone—SHBG—adipose tissue—metabolic syndrome X	0.00126	0.0486	CbGeAlD
Fluoxymesterone—AR—cardiovascular system—metabolic syndrome X	0.00102	0.0395	CbGeAlD
Fluoxymesterone—ESR1—cardiovascular system—metabolic syndrome X	0.00101	0.0388	CbGeAlD
Fluoxymesterone—AR—kidney—metabolic syndrome X	0.001	0.0387	CbGeAlD
Fluoxymesterone—ESR1—kidney—metabolic syndrome X	0.000984	0.038	CbGeAlD
Fluoxymesterone—AR—adipose tissue—metabolic syndrome X	0.000904	0.0348	CbGeAlD
Fluoxymesterone—ESR1—adipose tissue—metabolic syndrome X	0.000887	0.0342	CbGeAlD
Fluoxymesterone—SHBG—liver—metabolic syndrome X	0.000883	0.0341	CbGeAlD
Fluoxymesterone—NR3C1—cardiovascular system—metabolic syndrome X	0.000742	0.0286	CbGeAlD
Fluoxymesterone—NR3C1—kidney—metabolic syndrome X	0.000726	0.028	CbGeAlD
Fluoxymesterone—NR3C1—adipose tissue—metabolic syndrome X	0.000655	0.0252	CbGeAlD
Fluoxymesterone—AR—liver—metabolic syndrome X	0.000634	0.0244	CbGeAlD
Fluoxymesterone—ESR1—liver—metabolic syndrome X	0.000622	0.024	CbGeAlD
Fluoxymesterone—Danazol—CCL2—metabolic syndrome X	0.000588	0.0793	CrCbGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—metabolic syndrome X	0.000499	0.00443	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—metabolic syndrome X	0.000487	0.00432	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL18—metabolic syndrome X	0.000482	0.00428	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—metabolic syndrome X	0.000476	0.00422	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SCD—metabolic syndrome X	0.000471	0.00418	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—SREBF1—metabolic syndrome X	0.000471	0.00418	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—SIRT1—metabolic syndrome X	0.000462	0.0041	CbGpPWpGaD
Fluoxymesterone—NR3C1—liver—metabolic syndrome X	0.000459	0.0177	CbGeAlD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—NR3C1—metabolic syndrome X	0.000423	0.00375	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptors—PPARG—metabolic syndrome X	0.000414	0.00368	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling events mediated by HDAC Class II—NR3C1—metabolic syndrome X	0.000412	0.00366	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptors—NR3C1—metabolic syndrome X	0.000412	0.00366	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—NR3C1—metabolic syndrome X	0.00041	0.00364	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—APOB—metabolic syndrome X	0.000407	0.00361	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.000396	0.00352	CbGpPWpGaD
Fluoxymesterone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—metabolic syndrome X	0.000389	0.00345	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptors—PPARA—metabolic syndrome X	0.000386	0.00343	CbGpPWpGaD
Fluoxymesterone—Desoximetasone—NR3C1—metabolic syndrome X	0.000382	0.0515	CrCbGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—PPARA—metabolic syndrome X	0.00038	0.00338	CbGpPWpGaD
Fluoxymesterone—Loteprednol—NR3C1—metabolic syndrome X	0.000377	0.0509	CrCbGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—LPL—metabolic syndrome X	0.000375	0.00333	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—LBP—metabolic syndrome X	0.000373	0.00331	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—TGFB1—metabolic syndrome X	0.000361	0.00321	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—INS—metabolic syndrome X	0.000361	0.00321	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CD36—metabolic syndrome X	0.000357	0.00316	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IRS1—metabolic syndrome X	0.000352	0.00313	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—SIRT1—metabolic syndrome X	0.000351	0.00311	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—TNF—metabolic syndrome X	0.000338	0.003	CbGpPWpGaD
Fluoxymesterone—Danazol—SHBG—metabolic syndrome X	0.000335	0.0451	CrCbGaD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.000327	0.00291	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—NR3C1—metabolic syndrome X	0.000326	0.00289	CbGpPWpGaD
Fluoxymesterone—Hydrocortamate—NR3C1—metabolic syndrome X	0.000323	0.0436	CrCbGaD
Fluoxymesterone—Spironolactone—SHBG—metabolic syndrome X	0.000321	0.0432	CrCbGaD
Fluoxymesterone—ESR1—Nuclear Receptors—PPARG—metabolic syndrome X	0.000319	0.00283	CbGpPWpGaD
Fluoxymesterone—Cortisone acetate—NR3C1—metabolic syndrome X	0.000318	0.0429	CrCbGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—metabolic syndrome X	0.000317	0.00282	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—PPARG—metabolic syndrome X	0.000314	0.00279	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PLA2G6—metabolic syndrome X	0.000307	0.00273	CbGpPWpGaD
Fluoxymesterone—Megestrol acetate—NR3C1—metabolic syndrome X	0.000307	0.0414	CrCbGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—SIRT1—metabolic syndrome X	0.000305	0.00271	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.000305	0.00271	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—SHBG—metabolic syndrome X	0.000301	0.0405	CrCbGaD
Fluoxymesterone—Amcinonide—NR3C1—metabolic syndrome X	0.000301	0.0405	CrCbGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.000301	0.00267	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—GCK—metabolic syndrome X	0.0003	0.00267	CbGpPWpGaD
Fluoxymesterone—Norethindrone—SHBG—metabolic syndrome X	0.000298	0.0402	CrCbGaD
Fluoxymesterone—NR3C1—Adipogenesis—TRIB3—metabolic syndrome X	0.000296	0.00263	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—metabolic syndrome X	0.000292	0.00259	CbGpPWpGaD
Fluoxymesterone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—metabolic syndrome X	0.000289	0.00257	CbGpPWpGaD
Fluoxymesterone—Mometasone—NR3C1—metabolic syndrome X	0.000286	0.0385	CrCbGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—IGF1—metabolic syndrome X	0.000285	0.00253	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—PPARA—metabolic syndrome X	0.000283	0.00251	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TRIB3—metabolic syndrome X	0.000283	0.00251	CbGpPWpGaD
Fluoxymesterone—Methyltestosterone—SHBG—metabolic syndrome X	0.000283	0.0381	CrCbGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—INS—metabolic syndrome X	0.000278	0.00247	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—metabolic syndrome X	0.000274	0.00243	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—IL6—metabolic syndrome X	0.000272	0.00242	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—HMGCR—metabolic syndrome X	0.000269	0.00239	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—metabolic syndrome X	0.000268	0.00238	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—NAMPT—metabolic syndrome X	0.000265	0.00236	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—TRIB3—metabolic syndrome X	0.000265	0.00235	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—metabolic syndrome X	0.000259	0.00229	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—NOS3—metabolic syndrome X	0.000258	0.00229	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.000257	0.00228	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—NR3C1—metabolic syndrome X	0.000253	0.00224	CbGpPWpGaD
Fluoxymesterone—Fludrocortisone—NR3C1—metabolic syndrome X	0.000252	0.034	CrCbGaD
Fluoxymesterone—Clobetasol propionate—NR3C1—metabolic syndrome X	0.000252	0.034	CrCbGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.000252	0.00224	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—metabolic syndrome X	0.000251	0.00223	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.000248	0.00221	CbGpPWpGaD
Fluoxymesterone—Fluorometholone—NR3C1—metabolic syndrome X	0.000243	0.0328	CrCbGaD
Fluoxymesterone—NR3C1—Adipogenesis—HMGA1—metabolic syndrome X	0.000241	0.00214	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IL6—metabolic syndrome X	0.00024	0.00213	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SREBF1—metabolic syndrome X	0.000237	0.0021	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—AGT—metabolic syndrome X	0.000229	0.00204	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—GCK—metabolic syndrome X	0.000228	0.00202	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—AGT—metabolic syndrome X	0.000226	0.00201	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—metabolic syndrome X	0.000225	0.002	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—AKT1—metabolic syndrome X	0.000222	0.00197	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—INS—metabolic syndrome X	0.00022	0.00195	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CYBA—metabolic syndrome X	0.000219	0.00194	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—ADIPOQ—metabolic syndrome X	0.000217	0.00193	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—PTGS2—metabolic syndrome X	0.000216	0.00191	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—SHBG—metabolic syndrome X	0.000213	0.0287	CrCbGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—LEP—metabolic syndrome X	0.000213	0.00189	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—SERPINE1—metabolic syndrome X	0.000211	0.00187	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HDAC3—metabolic syndrome X	0.00021	0.00186	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IL6—metabolic syndrome X	0.000209	0.00185	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—HMGCR—metabolic syndrome X	0.000207	0.00184	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SLC2A4—metabolic syndrome X	0.000205	0.00182	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—metabolic syndrome X	0.000204	0.00181	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—SIRT1—metabolic syndrome X	0.0002	0.00178	CbGpPWpGaD
Fluoxymesterone—Triamcinolone—NR3C1—metabolic syndrome X	0.000198	0.0267	CrCbGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.000198	0.00176	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.000195	0.00173	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—AKT1—metabolic syndrome X	0.000193	0.00171	CbGpPWpGaD
Fluoxymesterone—Spironolactone—NR3C1—metabolic syndrome X	0.000191	0.0257	CrCbGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—IRS1—metabolic syndrome X	0.00019	0.00168	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCL2—metabolic syndrome X	0.000189	0.00168	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—AKT1—metabolic syndrome X	0.000189	0.00167	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.000188	0.00167	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000188	0.00167	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCL2—metabolic syndrome X	0.000186	0.00165	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TRIB3—metabolic syndrome X	0.000183	0.00162	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RBP4—metabolic syndrome X	0.000183	0.00162	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—NR3C1—metabolic syndrome X	0.000179	0.0241	CrCbGaD
Fluoxymesterone—PRLR—Immune System—VCAM1—metabolic syndrome X	0.000178	0.00158	CbGpPWpGaD
Fluoxymesterone—Progesterone—SHBG—metabolic syndrome X	0.000174	0.0234	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—NR3C1—metabolic syndrome X	0.000173	0.00153	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.000172	0.00153	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EDC4—metabolic syndrome X	0.000169	0.0015	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.000166	0.00147	CbGpPWpGaD
Fluoxymesterone—Prednisolone—NR3C1—metabolic syndrome X	0.000166	0.0223	CrCbGaD
Fluoxymesterone—Testosterone—SHBG—metabolic syndrome X	0.000164	0.0221	CrCbGaD
Fluoxymesterone—Betamethasone—NR3C1—metabolic syndrome X	0.000162	0.0219	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOC3—metabolic syndrome X	0.000162	0.00144	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—LPL—metabolic syndrome X	0.000161	0.00143	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—NOS3—metabolic syndrome X	0.000159	0.00141	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.000159	0.00141	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL18—metabolic syndrome X	0.000157	0.0014	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—metabolic syndrome X	0.000157	0.00139	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—metabolic syndrome X	0.000155	0.00137	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—SIRT1—metabolic syndrome X	0.000154	0.00137	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—metabolic syndrome X	0.000147	0.00131	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR2C—metabolic syndrome X	0.000146	0.0013	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD36—metabolic syndrome X	0.000146	0.0013	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—metabolic syndrome X	0.000145	0.00129	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.000145	0.00129	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.000143	0.00127	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—PPARA—metabolic syndrome X	0.000142	0.00126	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CYBA—metabolic syndrome X	0.000142	0.00126	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—IRS1—metabolic syndrome X	0.000141	0.00125	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GHRL—metabolic syndrome X	0.000139	0.00123	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—AGT—metabolic syndrome X	0.000138	0.00122	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—LEP—metabolic syndrome X	0.000135	0.0012	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.000132	0.00118	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CRP—metabolic syndrome X	0.000132	0.00117	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CNR1—metabolic syndrome X	0.000131	0.00117	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EDC4—metabolic syndrome X	0.000131	0.00116	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.00013	0.00116	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EDC4—metabolic syndrome X	0.000129	0.00114	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.000128	0.00113	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—NR3C1—metabolic syndrome X	0.000127	0.0171	CrCbGaD
Fluoxymesterone—AR—Gene Expression—NR1H3—metabolic syndrome X	0.000124	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.000122	0.00109	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IRS1—metabolic syndrome X	0.00012	0.00107	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—AKT1—metabolic syndrome X	0.000119	0.00105	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—PPARG—metabolic syndrome X	0.000118	0.00104	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—INS—metabolic syndrome X	0.000115	0.00102	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IRS1—metabolic syndrome X	0.000115	0.00102	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—TGFB1—metabolic syndrome X	0.000114	0.00101	CbGpPWpGaD
Fluoxymesterone—Triamcinolone—PTGS2—metabolic syndrome X	0.000112	0.0152	CrCbGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—TGFB1—metabolic syndrome X	0.000112	0.000996	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—AKT1—metabolic syndrome X	0.000112	0.000996	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IGF1—metabolic syndrome X	0.000111	0.00099	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TGFB1—metabolic syndrome X	0.000111	0.000989	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—metabolic syndrome X	0.000111	0.000981	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TGFB1—metabolic syndrome X	0.00011	0.000974	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—IRS1—metabolic syndrome X	0.000108	0.000962	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.000108	0.000959	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IRS1—metabolic syndrome X	0.000108	0.000957	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF2—metabolic syndrome X	0.000107	0.000953	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SERPINE1—metabolic syndrome X	0.000106	0.00094	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOB—metabolic syndrome X	0.000104	0.000925	CbGpPWpGaD
Fluoxymesterone—Progesterone—NR3C1—metabolic syndrome X	0.000103	0.0139	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL5—metabolic syndrome X	0.000102	0.000903	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000101	0.0009	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LPL—metabolic syndrome X	9.95e-05	0.000883	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—metabolic syndrome X	9.62e-05	0.000854	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR1H3—metabolic syndrome X	9.52e-05	0.000845	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—NR3C1—metabolic syndrome X	9.44e-05	0.0127	CrCbGaD
Fluoxymesterone—NR3C1—Gene Expression—NR1H3—metabolic syndrome X	9.38e-05	0.000833	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PTGS2—metabolic syndrome X	9.21e-05	0.0124	CrCbGaD
Fluoxymesterone—AR—Gene Expression—NR1I3—metabolic syndrome X	9.05e-05	0.000803	CbGpPWpGaD
Fluoxymesterone—Norethindrone—ALB—metabolic syndrome X	8.96e-05	0.0121	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	8.96e-05	0.000795	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—metabolic syndrome X	8.94e-05	0.000794	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AGT—metabolic syndrome X	8.51e-05	0.000756	CbGpPWpGaD
Fluoxymesterone—Methyltestosterone—ALB—metabolic syndrome X	8.51e-05	0.0115	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—metabolic syndrome X	8.39e-05	0.000745	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LEP—metabolic syndrome X	8.34e-05	0.00074	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOE—metabolic syndrome X	8.34e-05	0.00074	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	8.32e-05	0.000739	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—metabolic syndrome X	8.29e-05	0.000736	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR1I2—metabolic syndrome X	8.28e-05	0.000735	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—metabolic syndrome X	8.26e-05	0.000734	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOA1—metabolic syndrome X	8.24e-05	0.000732	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—metabolic syndrome X	7.92e-05	0.000703	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IRS1—metabolic syndrome X	7.44e-05	0.00066	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—metabolic syndrome X	7.33e-05	0.00065	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR3C1—metabolic syndrome X	7.3e-05	0.000648	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—metabolic syndrome X	7.28e-05	0.000646	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—INS—metabolic syndrome X	7.12e-05	0.000632	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	7.11e-05	0.000631	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL2—metabolic syndrome X	7.01e-05	0.000622	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR1I3—metabolic syndrome X	6.97e-05	0.000619	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	6.9e-05	0.000613	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1—metabolic syndrome X	6.89e-05	0.000612	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—metabolic syndrome X	6.89e-05	0.000611	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR1I3—metabolic syndrome X	6.87e-05	0.000609	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARA—metabolic syndrome X	6.84e-05	0.000607	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—metabolic syndrome X	6.78e-05	0.000602	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—metabolic syndrome X	6.72e-05	0.000596	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—metabolic syndrome X	6.68e-05	0.000593	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SERPINE1—metabolic syndrome X	6.54e-05	0.000581	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	6.48e-05	0.000575	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR1I2—metabolic syndrome X	6.38e-05	0.000566	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR1I2—metabolic syndrome X	6.28e-05	0.000557	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOS3—metabolic syndrome X	6.25e-05	0.000555	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—metabolic syndrome X	6.24e-05	0.000554	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	6.05e-05	0.000537	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	5.74e-05	0.000509	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—metabolic syndrome X	5.66e-05	0.000502	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR3C1—metabolic syndrome X	5.63e-05	0.000499	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—metabolic syndrome X	5.43e-05	0.000482	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	5.39e-05	0.000479	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—metabolic syndrome X	5.36e-05	0.00722	CrCbGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARA—metabolic syndrome X	5.27e-05	0.000468	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARA—metabolic syndrome X	5.19e-05	0.000461	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	5.1e-05	0.000452	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—metabolic syndrome X	5.04e-05	0.000447	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	4.99e-05	0.000443	CbGpPWpGaD
Fluoxymesterone—Testosterone—ALB—metabolic syndrome X	4.94e-05	0.00665	CrCbGaD
Fluoxymesterone—PRLR—Immune System—IL6—metabolic syndrome X	4.82e-05	0.000427	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	4.66e-05	0.000414	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—metabolic syndrome X	4.51e-05	0.000401	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	4.5e-05	0.0004	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—metabolic syndrome X	4.44e-05	0.000394	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—metabolic syndrome X	4.36e-05	0.000387	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	4.35e-05	0.000386	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—metabolic syndrome X	4.29e-05	0.000381	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—metabolic syndrome X	4.19e-05	0.000372	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—metabolic syndrome X	4.16e-05	0.00037	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—metabolic syndrome X	4.13e-05	0.000367	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SIRT1—metabolic syndrome X	3.96e-05	0.000352	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC3—metabolic syndrome X	3.94e-05	0.00035	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	3.93e-05	0.000348	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	3.87e-05	0.000343	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTNR1B—metabolic syndrome X	3.52e-05	0.000313	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR3C1—metabolic syndrome X	3.52e-05	0.000312	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	3.47e-05	0.000308	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TRIB3—metabolic syndrome X	3.43e-05	0.000305	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RBP4—metabolic syndrome X	3.43e-05	0.000305	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARA—metabolic syndrome X	3.29e-05	0.000292	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—metabolic syndrome X	3.11e-05	0.000276	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SIRT1—metabolic syndrome X	3.05e-05	0.000271	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOC3—metabolic syndrome X	3.04e-05	0.00027	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SIRT1—metabolic syndrome X	3.01e-05	0.000267	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—metabolic syndrome X	2.87e-05	0.000255	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR2C—metabolic syndrome X	2.75e-05	0.000244	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—metabolic syndrome X	2.72e-05	0.000242	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR3C1—metabolic syndrome X	2.71e-05	0.00024	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CYBA—metabolic syndrome X	2.66e-05	0.000236	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GHRL—metabolic syndrome X	2.6e-05	0.000231	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARA—metabolic syndrome X	2.54e-05	0.000225	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARA—metabolic syndrome X	2.5e-05	0.000222	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CNR1—metabolic syndrome X	2.47e-05	0.000219	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SERPINE1—metabolic syndrome X	2.45e-05	0.000218	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—metabolic syndrome X	2.1e-05	0.000186	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—metabolic syndrome X	2.07e-05	0.000183	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF2—metabolic syndrome X	2.02e-05	0.000179	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOB—metabolic syndrome X	1.96e-05	0.000174	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL5—metabolic syndrome X	1.91e-05	0.00017	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.9e-05	0.000169	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SERPINE1—metabolic syndrome X	1.89e-05	0.000168	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LPL—metabolic syndrome X	1.87e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SERPINE1—metabolic syndrome X	1.86e-05	0.000165	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGT—metabolic syndrome X	1.6e-05	0.000142	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEP—metabolic syndrome X	1.57e-05	0.000139	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOE—metabolic syndrome X	1.57e-05	0.000139	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOA1—metabolic syndrome X	1.55e-05	0.000137	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS1—metabolic syndrome X	1.4e-05	0.000124	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INS—metabolic syndrome X	1.34e-05	0.000119	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL2—metabolic syndrome X	1.32e-05	0.000117	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1—metabolic syndrome X	1.29e-05	0.000115	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.23e-05	0.000109	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOS3—metabolic syndrome X	1.17e-05	0.000104	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—metabolic syndrome X	1.08e-05	9.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—metabolic syndrome X	8.29e-06	7.36e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—metabolic syndrome X	8.17e-06	7.25e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—metabolic syndrome X	7.76e-06	6.89e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—metabolic syndrome X	5.85e-06	5.19e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—metabolic syndrome X	5.39e-06	4.79e-05	CbGpPWpGaD
